Ana Stankovic, MD
Nephrology · Salem, NHNPI 1992794515
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $49,065 of the $66,412 with a category attached, or 73.9%. 20 manufacturers reported payments, led by Bayer at 26.3% of the total. Reporting peaked in 2021 at $23,167 and has fallen 91.6% since, to $1,950 in 2023. Among nephrology clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $897.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$17K
- Johnson & Johnson$11K
- Janssen Scientific Affairs, LLC$6K
- Vifor Pharma, Inc.$5K
- Boehringer Ingelheim$4K
- AstraZeneca$4K
- plus $18K from 14 others
What the payments were for
- Consulting fees$49,06574%
- Speaking & faculty fees$13,22720%
- Travel & lodging$3,0345%
- Food & beverage$1,0872%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 17 | $17,456 |
| Johnson & Johnson | 15 | $11,413 |
| Janssen Scientific Affairs, LLC | 14 | $5,883 |
| Vifor Pharma, Inc. | 8 | $5,208 |
| Boehringer Ingelheim | 2 | $4,130 |
| AstraZeneca(2 entities) | 4 | $3,912 |
| Sage Therapeutics, LLC | 1 | $2,061 |
| Lilly USA, LLC | 1 | $2,025 |
| Greiner Bio-one North America, Inc. | 1 | $2,000 |
| Mallinckrodt Enterprises LLC | 1 | $1,900 |
| Pfizer | 1 | $1,800 |
| Taiho Oncology, Inc. | 1 | $1,660 |
| CSL Behring | 1 | $1,600 |
| GSK | 1 | $1,380 |
| Eisai Inc. | 1 | $1,290 |
| Seagen Inc. | 1 | $1,000 |
| Amgen | 1 | $850 |
| Taro Pharmaceuticals USA, Inc. | 1 | $375 |
| Fresenius USA Marketing, Inc. | 1 | $355 |
| Novo Nordisk | 1 | $114 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$66,412 in reported general payments places this provider in the 95th percentile of 33 nephrology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 38 | $3,617 |
| Nebivolol Hcl | 12 | $1,239 |
| Amlodipine Besylate | 197 | $1,239 |
| Colchicine | 18 | $1,089 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 67 | $1,064 |
| Losartan Potassium | 72 | $871 |
| Valsartan | 21 | $730 |
| Torsemide | 25 | $652 |
| Hydralazine Hcl | 65 | $577 |
| Spironolactone | 53 | $552 |
| Carvedilol | 38 | $548 |
| Lisinopril | 102 | $543 |
| Metoprolol Succinate | 42 | $511 |
| Olmesartan Medoxomil | 22 | $505 |
| Potassium Chloride | 18 | $442 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Salem
- Elizabeth BrandtLebanon$41K
- John Patrick SiaManchester$12K
- Sucharit JoshiPortsmouth$6K
- Yishu HanConcord$1K
- Shaikh HoqueNashua$740
- Siddharth MehtaNashua$589
- Krupa RajurNashua$438
- Beri SongnaNashua$425
- Sean FitzpatrickNashua$401
- Maged LotfallaKeene$397
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.